Upfront surgery in patients with epithelial ovarian cancer and enlarged supradiaphragmatic lymph nodes associated with comparable to neoadjuvant chemotherapy

Autor: Omer Weitzner, Yael Yagur, Yfat Kadan, Ami Fishman, Rivka Zissin, Emilie Ben-Ezry, Limor Helpman, Mario E. Beiner

Publikováno v: BMC Women's Health, Vol 22, Iss 1, Pp 1-6 (2022)

Abstract Background There is little data regarding the optimal approach to advanced epithelial ovarian cancer (EOC) with isolated extra-peritoneal disease in the cardiophrenic lymph nodes. This study assessed whether the prognosis and surgical outcom

Externí odkaz: https://doaj.org/article/1457246385c14e509794cbb87bc42d02

Predictors of uncommon location of sentinel nodes in endometrial and cervical cancers

Autor: Yfat Kadan, Alexandra Baron, Yoav Brezinov, Alon Ben Arie, Ami Fishman, Mario Beiner

Publikováno v: Gynecologic Oncology Reports, Vol 39, Iss , Pp 100917- (2022)

Objective: Sentinel node mapping is widely used in the treatment of gynecologic cancers. The current study aimed to identify predictors of uncommon sentinel lymph node (SLN) locations. Methods: The current study included women who were operated for e

Externí odkaz: https://doaj.org/article/699c9bedacbe44f0b8e6fe36b1751aa5

Noninvasive test for the diagnosis of ovarian hormone-secreting-neoplasm in postmenopausal women

Autor: Ilan Cohen, Dan Nabriski, Ami Fishman

Publikováno v: Gynecologic Oncology Reports, Vol 15, Iss C, Pp 12-15 (2016)

Context: The diagnosis of ovarian hormone-secreting neoplasm in postmenopausal women is currently based on imaging modalities and selective venography. However, these diagnostic tests are not always accurate. In order to improve and simplify the diag

Externí odkaz: https://doaj.org/article/8ac5a4ad99a7435782d2b26ec1c28afe

Corrigendum to 'DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and metabolic reprogramming in high grade serous ovarian cancer' [Canc. Lett. 501 224–233]

Autor: Dotan Moskovich, Adi Alfandari, Yael Finkelshtein, Avivit Weisz, Aviva Katzav, Debora Kidron, Evgeny Edelstein, Daniel Veroslavski, Ruth Perets, Nissim Arbib, Yfat Kadan, Ami Fishman, Bernard Lerer, Martin Ellis, Osnat Ashur-Fabian

Publikováno v: Cancer Letters. 563:216196

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1b19a1c38758b3610eedab375e055cb6
https://doi.org/10.1016/j.canlet.2023.216196

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21)

Autor: Andrés Poveda, Anne Floquet, Jonathan A Ledermann, Rebecca Asher, Richard T Penson, Amit M Oza, Jacob Korach, Tomasz Huzarski, Sandro Pignata, Michael Friedlander, Alessandra Baldoni, Tjoung-Won Park-Simon, Kenji Tamura, Gabe S Sonke, Alla Lisyanskaya, Jae-Hoon Kim, Elias Abdo Filho, Tsveta Milenkova, Elizabeth S Lowe, Phil Rowe, Ignace Vergote, Eric Pujade-Lauraine, Tomasz Byrski, Patricia Pautier, Philipp Harter, Nicoletta Colombo, Giovanni Scambia, Maria Nicoletto, Fiona Nussey, Andrew Clamp, Richard Penson, Amit Oza, Andrés Poveda Velasco, Manuel Rodrigues, Jean-Pierre Lotz, Frédéric Selle, Isabelle Ray-Coquard, Diane Provencher, Aleix Prat Aparicio, Laura Vidal Boixader, Clare Scott, Mayu Yunokawa, Jacques Medioni, Nicolas Pécuchet, Coraline Dubot, Thibault De La Motte Rouge, Marie-Christine Kaminsky, Béatrice Weber, Alain Lortholary, Christine Parkinson, Jonathan Ledermann, Sarah Williams, Susana Banerjee, Jonathan Cosin, James Hoffman, Marie Plante, Allan Covens, Gabe Sonke, Florence Joly, Holger Hirte, Amnon Amit, Koji Matsumoto, Sergei Tjulandin, Jae Hoon Kim, Laurence Gladieff, Roberto Sabbatini, David O'Malley, Patrick Timmins, Daniel Kredentser, Nuria Laínez Milagro, Maria Pilar Barretina Ginesta, Ariadna Tibau Martorell, Alfonso Gómez De Liaño Lista, Belén Ojeda González, Linda Mileshkin, Masaki Mandai, Ingrid Boere, Petronella Ottevanger, Joo-Hyun Nam, Elias Filho, Salima Hamizi, Francesco Cognetti, David Warshal, Elizabeth Dickson-Michelson, Scott Kamelle, Nathalie McKenzie, Gustavo Rodriguez, Deborah Armstrong, Eva Chalas, Paul Celano, Kian Behbakht, Susan Davidson, Stephen Welch, Limor Helpman, Ami Fishman, Ilan Bruchim, Magdalena Sikorska, Anna Słowińska, Wojciech Rogowski, Mariusz Bidziński, Beata Śpiewankiewicz, Antonio Casado Herraez, César Mendiola Fernández, Martina Gropp-Meier, Toshiaki Saito, Kazuhiro Takehara, Takayuki Enomoto, Hidemichi Watari, Chel Hun Choi, Byoung-Gie Kim, Jae Weon Kim, Roberto Hegg

Publikováno v: Lancet Oncology, 22, 5, pp. 620-631
Lancet Oncology, 22, 620-631
The Lancet Oncology, 22(5), 620-631. Lancet Publishing Group

Contains fulltext : 241226.pdf (Publisher’s version ) (Closed access) BACKGROUND: Olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, has previously been shown to extend progression-free survival versus placebo when given to patients with re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327550b0b53fe7a798b4b4246c0e4f41
https://doi.org/10.1016/s1470-2045(21)00073-5